Schonfeld Strategic Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-538,836
Closed -$62.3M 2203
2023
Q3
$62.3M Buy
538,836
+371,452
+222% +$43M 0.48% 18
2023
Q2
$17.2M Buy
167,384
+142,842
+582% +$14.7M 0.15% 212
2023
Q1
$2.68M Sell
24,542
-127,990
-84% -$14M 0.03% 607
2022
Q4
$17.4M Sell
152,532
-7,811
-5% -$889K 0.14% 205
2022
Q3
$9.92M Buy
160,343
+44,422
+38% +$2.75M 0.08% 310
2022
Q2
$9.25M Buy
115,921
+57,881
+100% +$4.62M 0.09% 268
2022
Q1
$6.11M Buy
58,040
+36,840
+174% +$3.88M 0.06% 354
2021
Q4
$2.28M Sell
21,200
-47,909
-69% -$5.16M 0.02% 614
2021
Q3
$7.57M Buy
69,109
+16,392
+31% +$1.8M 0.08% 295
2021
Q2
$4.94M Buy
52,717
+11,154
+27% +$1.04M 0.05% 444
2021
Q1
$3.83M Buy
41,563
+18,263
+78% +$1.68M 0.05% 472
2020
Q4
$1.7M Sell
23,300
-109,175
-82% -$7.98M 0.02% 615
2020
Q3
$10.3M Buy
132,475
+87,663
+196% +$6.81M 0.2% 130
2020
Q2
$2.49M Buy
44,812
+17,845
+66% +$992K 0.06% 326
2020
Q1
$799K Sell
26,967
-18,442
-41% -$546K 0.05% 435
2019
Q4
$1.65M Sell
45,409
-186,573
-80% -$6.76M 0.04% 375
2019
Q3
$6.32M Buy
231,982
+159,443
+220% +$4.34M 0.19% 142
2019
Q2
$1.75M Buy
+72,539
New +$1.75M 0.06% 317
2017
Q1
Sell
-20,000
Closed -$324K 808
2016
Q4
$324K Sell
20,000
-13,109
-40% -$212K 0.04% 411
2016
Q3
$600K Buy
33,109
+21,636
+189% +$392K 0.1% 248
2016
Q2
$189K Sell
11,473
-65,902
-85% -$1.09M 0.04% 382
2016
Q1
$1.28M Buy
+77,375
New +$1.28M 0.52% 48